Hybio Pharmaceutical Co Ltd SZSE:300199:
UNIT'S LIRAGLUTIDE(H) APPROVED BY CHINA'S NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Hybio Pharmaceutical Unit's Chemical API Liraglutide Approved By China's Regulator
Earlier from Hybio Pharmaceutical Co., Ltd. Class A
- Hybio Pharmaceutical's Liraglutide Injection Approved By China's National Medical Products Administration
- Hybio's generic weight-loss drug set for FDA review
- Hybio Pharmaceutical Plans To Raise Fund Via Share Private Placement